![Robert M. Brenner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert M. Brenner
Technik-/Wissenschafts-/F&E-Leiter bei VERA THERAPEUTICS, INC.
Aktive Positionen von Robert M. Brenner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.01.2023 | - |
Karriereverlauf von Robert M. Brenner
Ehemalige bekannte Positionen von Robert M. Brenner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CODIAK BIOSCIENCES | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 | 01.03.2019 |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2015 | 01.09.2018 |
AMAG PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2008 | 04.06.2010 |
AMGEN INC. | Corporate Officer/Principal | 01.07.1999 | 01.05.2008 |
AlloCure, Inc.
![]() AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Direktor/Vorstandsmitglied | 28.12.2010 | - |
Vorstandsvorsitzender | 07.07.2010 | - | |
Präsident | 07.07.2010 | - |
Ausbildung von Robert M. Brenner
The Johns Hopkins University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AMGEN INC. | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
AMAG Pharmaceuticals, Inc.
![]() AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
AlloCure, Inc.
![]() AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Health Technology |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | Technology Services |
Codiak BioSciences, Inc.
![]() Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Robert M. Brenner
- Erfahrung